Prophylaxis of venous thrombosis and low-molecular-weight heparin
Vallano, A.; Arnau, J.M.; Vallés, J.A.
Medicina Clinica 97(7): 272-275
1991
ISSN/ISBN: 0025-7753 PMID: 1658499 Document Number: 370052
Document emailed within 1 workday
Related Documents
Wei, N.; Qi, Y.; Yang, H.; Guo, L. 2018: Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery Pakistan Journal of Pharmaceutical Sciences 31(6(Special): 2835-2839Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609
Nesvold, A.; Ly, B.; Abildgaard, U.; Stiris, M. 1991: Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(27): 3296-3297
Stephan, D.; Welsch, M.; Chapatte, D.; Weltin, D.; Imbs, J.L. 1999: Deep venous thrombosis during pregnancy: long-term treatment with low molecular weight heparin Presse Medicale 28(34): 1880
Lamy, O.; Cornuz, J.; Yersin, B. 1999: Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review Schweizerische Medizinische Wochenschrift 129(18): 707-714
Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F.; Blümel, G. 1987: Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittel-Forschung 37(7): 839-843
Hull, R.D.; Pineo, G.F.; Stein, P.D.; Mah, A.F.; MacIsaac, S.M.; Dahl, O.E.; Ghali, W.A.; Butcher, M.S.; Brant, R.F.; Bergqvist, D.; Hamulyák, K.; Francis, C.W.; Marder, V.J.; Raskob, G.E. 2001: Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review Archives of Internal Medicine 161(16): 1952-1960
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294
Bergqvist, D.; Wiklund, L. 2000: Caution for prophylaxis of thrombosis in connection with spinal anesthesia. Risk of hemorrhage when low-molecular-weight heparin is administered in epidural/spinal anesthesia Lakartidningen 97(49): 5762; 5765
Suomalainen, O. 1996: Low molecular heparin in the prophylaxis of postoperative thrombosis Duodecim; Laaketieteellinen Aikakauskirja 112(17): 1545-1551
Grunebaum, L.; Fricker, J.P.; Wiesel, M.L.; Vergnes, Y.; Kapps, J.; Cazenave, J.P. 1987: Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery Journal des Maladies Vasculaires 12 Suppl B: 102-104
Kiil, J.; Kiil, J.; Axelsen, F. 1978: Heparin in low dosage as prophylaxis of postoperative pulmonary embolism and deep venous thrombosis Ugeskrift for Laeger 140(21): 1224-1230
Velut, J.G.; Boubli, L.; Lheureux, G.; d'Ercole, C.; Harlé, J.R.; Bagnères, D.; Frances, Y. 2001: Low-molecular-weight heparin prophylaxis during pregnancy: a retrospective study in 119 women Presse Medicale 30(13): 635
Nikolov, A.; Kovachev, I.; Petkov, I.; Dimitrov, A. 2000: Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics Akusherstvo i Ginekologiia 39(3): 35-40
Haas, S. 1995: Combination of low molecular weight heparin and dihydroergotamine for prevention of thrombosis Deutsche Medizinische Wochenschrift 120(14): 503
Bacher, P.; Horst, B.; Breyer, H.G.; Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1993: Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patients Seminars in Thrombosis and Hemostasis 19(Suppl 1): 73-78
Forbes, C.D. 1989: Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin British Journal of Clinical Practice 43(11): 396-400
2003: Low molecular weight heparin certoparin. Clear simplification of thrombosis treatment MMW Fortschritte der Medizin 145(19): Suppl. 1-3
Jacobsen, A.F.; Qvigstad, E.; Sandset, P.M. 2000: Treatment of venous thromboembolism in pregnancy with low molecular weight heparin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2448-2449
Alonso Martínez, J.L.; Abínzano Guillén, M.L.; Urbieta Echezarreta, M.A.; Annichérico Sánchez, F.J.; Fernández Ladrón, V.; García Sanchotena, J.L. 2008: Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis Anales de Medicina Interna 25(1): 4-8